Cargando…
Duration of chemotherapy prior to chemoradiation affects survival outcomes for resected stage I‐II or unresected stage III pancreatic cancer
BACKGROUND: For resected early stage pancreatic cancer, RTOG 9704 evaluated the outcome of 3 weeks of postoperative chemotherapy (C) followed by chemoradiation (CRT) and further C. For unresectable locally advanced pancreatic cancer, a recent literature review of prospective studies showed that the...
Autores principales: | Ma, Sung J., Iovoli, Austin J., Hermann, Gregory M., Prezzano, Kavitha M., Singh, Anurag K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6675727/ https://www.ncbi.nlm.nih.gov/pubmed/31183965 http://dx.doi.org/10.1002/cam4.2326 |
Ejemplares similares
-
Adjuvant chemotherapy followed by concurrent chemoradiation is associated with improved survival for resected stage I‐II pancreatic cancer
por: Ma, Sung Jun, et al.
Publicado: (2019) -
Dose escalation of radiation therapy with or without induction chemotherapy for unresectable locally advanced pancreatic cancer
por: Ma, Sung Jun, et al.
Publicado: (2018) -
Intravenous fluids for pain management in head and neck cancer patients undergoing chemoradiation
por: Rivers, Charlotte I., et al.
Publicado: (2021) -
Association of Timing of Adjuvant Therapy With Survival in Patients With Resected Stage I to II Pancreatic Cancer
por: Ma, Sung Jun, et al.
Publicado: (2019) -
Concurrent Chemoradiation With or Without Durvalumab in Elderly Patients With Unresectable Stage III NSCLC: Safety and Efficacy
por: Lau, Sally C.M., et al.
Publicado: (2021)